First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Down 41.9% in August

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 134,463 shares, a decrease of 41.9% from the August 15th total of 231,413 shares. Based on an average trading volume of 130,940 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.6% of the company’s shares are sold short.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of FTXH. Compass Financial Management LLC bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the second quarter worth approximately $29,000. Nilsine Partners LLC boosted its stake in First Trust Nasdaq Pharmaceuticals ETF by 3.5% in the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after acquiring an additional 937 shares during the last quarter. Vivaldi Capital Management LP boosted its stake in First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after acquiring an additional 1,741 shares during the last quarter. Flputnam Investment Management Co. acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter worth $230,000. Finally, Marshall Investment Management LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter worth $1,377,000.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.3%

First Trust Nasdaq Pharmaceuticals ETF stock traded up $0.14 during mid-day trading on Wednesday, hitting $40.83. The stock had a trading volume of 29,748 shares, compared to its average volume of 220,345. The stock has a 50-day simple moving average of $40.09 and a two-hundred day simple moving average of $36.71. The stock has a market capitalization of $1.05 billion, a PE ratio of 14.51 and a beta of 0.46. First Trust Nasdaq Pharmaceuticals ETF has a 12 month low of $27.30 and a 12 month high of $42.87.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Thursday, June 25th were given a dividend of $0.092 per share. This represents a $0.37 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Thursday, June 25th. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.